替格瑞洛雜質(zhì)，替卡格雷雜質(zhì)對(duì)照品 產(chǎn)品介紹：
中文名稱：替格瑞洛雜質(zhì)，替卡格雷雜質(zhì)對(duì)照品
英文名稱：Ticagrelor Impurity
規(guī)格：10mg/25mg/50mg/100mg等多種規(guī)格可選。
用途：實(shí)驗(yàn)研發(fā)，藥品申報(bào)檢測(cè)，不得用于臨床醫(yī)學(xué)診斷。
隨貨提供：所有雜質(zhì)對(duì)照品均隨貨提供HPLC，NMR，MS圖譜及CoA證書(shū)。
保存及取用：為了防止產(chǎn)品含量降低，應(yīng)防潮，避光和抗氧化包裝，保存應(yīng)以提高物質(zhì)穩(wěn)定性為原則。如果一次使用很少量，可以將其適當(dāng)分裝后使用，這樣可以有效的防止試劑污染。請(qǐng)不要在臟亂和強(qiáng)光環(huán)境中取用，以免造成污染和失效。

替格瑞洛雜質(zhì)，替卡格雷雜質(zhì)對(duì)照品 雜質(zhì)列表：

Ticagrelor	(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 1	(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 2	(1S,2S,3R,5S)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 3	(1R,2R,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 4（Mixture of Diastereomers）	(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1)
Ticagrelor Impurity 5（Mixture of Diastereomers）	(1R,2R,3S,5R)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1R,2R,3S,5R)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1)
Ticagrelor Impurity 6	2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
Ticagrelor Impurity 7	(1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 8	(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 9	2-(((3aR,4S,6R,6aS)-6-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
Ticagrelor Impurity 10	5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol
Ticagrelor Impurity 11	2-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)oxy)ethanol
Ticagrelor Impurity 12	(1S,2S,3R,5S)-3-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 13	5-amino-6-(((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)amino)-2-(propylthio)pyrimidin-4-ol
Ticagrelor Impurity 14	(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 15	(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-methoxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 16	2-(((3aS,4R,6S,6aR)-6-((3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
Ticagrelor Impurity 17	(1R,2R,3S,5R)-3-((3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 18	(1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 19	(1S,2S,3R,5S)-3-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 20	(1S,2R,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol
Ticagrelor Impurity 21	(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 22	(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 23	sodium 7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-olate
Ticagrelor Impurity 24	(1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 25	(1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 26	2-((6-chloro-5-(7-(2-hydroxyethoxy)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2-(propylthio)pyrimidin-4-yl)oxy)ethanol
Ticagrelor Impurity 27	(1S,2S,3S,5R)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 28	7-chloro-3-(4,6-dichloro-2-(propylthio)pyrimidin-5-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidine
Ticagrelor Impurity 29	(1S,2S,3R,5S)-3-(2-hydroxyethoxy)-5-(5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2-diol
Ticagrelor Impurity 30	2-(((3aR,4R,6S,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol

若雜質(zhì)列表中未有您需要的雜質(zhì)，歡迎來(lái)電或在線詳詢，產(chǎn)品庫(kù)時(shí)常會(huì)有更新，另外，我司有專業(yè)研發(fā)團(tuán)隊(duì)，可提供部分雜質(zhì)定制服務(wù)，以最大可能的滿足您對(duì)雜質(zhì)對(duì)照品的選購(gòu)需求。

替格瑞洛雜質(zhì)，替卡格雷雜質(zhì)對(duì)照品 訂購(gòu)方式：
聯(lián)系人：何先生
手機(jī)：15012456311
QQ：781007885
郵箱：phastandards@gmail.com
歡迎您通過(guò)電話，電郵或在線客服向我司詢價(jià)及訂購(gòu)產(chǎn)品。

替格瑞洛雜質(zhì)，替卡格雷雜質(zhì)對(duì)照品  深圳遠(yuǎn)揚(yáng)專注醫(yī)藥標(biāo)準(zhǔn)品，雜質(zhì)對(duì)照品，更多產(chǎn)品，歡迎選購(gòu)（篇幅有限，只列舉了一小部分，更多更全，請(qǐng)來(lái)電詳詢）：
NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表：

01/534               Meningococcal serogroup W polysaccharide

13/223               C-Peptide, Human. 78st International Standard.

13/154               Influenza Antigen B/Massachusetts/02/2032 (Egg derived)

10/192               Reteplase Reference Material

10/119               Reteplase Reference Material

03/104-064         HTLV-49 (antibody) Monitor Sample

03/104-080         HTLV-65 (antibody) Monitor Sample

10/151               Reteplase Reference Material

12/B623-072       QCRFLUAH1N1QC1-Influenza AH1N1 QC70

12/B623-049       QCRFLUAH1N1QC1-Influenza AH1N1 QC47

13/149               C-Peptide, Human. 4st International Standard.

13/232               Influenza Antigen B/Massachusetts/02/2110 (Egg derived)

10/195               Reteplase Reference Material

10/204               Reteplase Reference Material

12/B623-060       QCRFLUAH1N1QC1-Influenza AH1N1 QC58

03/104-061         HTLV-46 (antibody) Monitor Sample

13/189               Influenza Antigen B/Massachusetts/02/2067 (Egg derived)

07/343               BCG Vaccine of Russian BCG-I sub-strain(70st WHO Reference Reagent)

13/292               Polio Anti Sabin type 75 (inactivated) Serum

10/143               Reteplase Reference Material

10/158               Reteplase Reference Material

13/156               C-Peptide, Human. 11st International Standard.

07/370               BCG Vaccine of Russian BCG-I sub-strain(97st WHO Reference Reagent)

13/141               Influenza Antigen B/Massachusetts/02/2019 (Egg derived)

95/557               Interleukin-18 (Human, rDNA derived)

95/568               Interleukin-29 (Human, rDNA derived)

13/181               Influenza Antigen B/Massachusetts/02/2059 (Egg derived)

95/574               Interleukin-35 (Human, rDNA derived)

13/222               C-Peptide, Human. 77st International Standard.

07/296               BCG Vaccine of Russian BCG-I sub-strain(23st WHO Reference Reagent)

13/275               Polio Anti Sabin type 58 (inactivated) Serum

03/104-109         HTLV-94 (antibody) Monitor Sample

10/164               Reteplase Reference Material

95/625               Interleukin-86 (Human, rDNA derived)

10/134               Reteplase Reference Material

10/110               Reteplase Reference Material

13/323               Polio Anti Sabin type 106 (inactivated) Serum

10/202               Reteplase Reference Material

10/168               Reteplase Reference Material

10/129               Reteplase Reference Material

03/104-123         HTLV-108 (antibody) Monitor Sample

替格瑞洛雜質(zhì)，替卡格雷雜質(zhì)對(duì)照品  雜質(zhì)對(duì)照品部分產(chǎn)品列表：

別嘌醇雜質(zhì)，亞胺培南雜質(zhì)，氫溴酸西酞普蘭雜質(zhì)，比魯卡因雜質(zhì)， ，普里米酮雜質(zhì)，布美他尼雜質(zhì)，伊班膦酸鈉雜質(zhì)，羅沙替丁雜質(zhì)，格列吡嗪雜質(zhì)，沃替西汀雜質(zhì)，鹽酸阿夫唑嗪雜質(zhì)，地拉羅司雜質(zhì)，馬西替坦雜質(zhì)，芐絲肼雜質(zhì)，鹽酸特拉唑嗪雜質(zhì)，艾普拉唑雜質(zhì)，吡羅昔康雜質(zhì)，丁呋洛爾雜質(zhì)，文拉法辛雜質(zhì)，阿替洛爾雜質(zhì)，地西他濱雜質(zhì)，氟喹酮雜質(zhì)，醋氯芬酸雜質(zhì)，凡德他尼雜質(zhì)，卡泊芬凈雜質(zhì)，噻托溴銨雜質(zhì)，昂丹司瓊雜質(zhì)，貝沙羅汀雜質(zhì)，萬(wàn)古霉素雜質(zhì)，地諾孕素雜質(zhì)，依匹唑派雜質(zhì)，甲磺酸帕珠沙星，阿斯巴甜雜質(zhì)，西那卡塞雜質(zhì)，蘭索拉唑雜質(zhì)，LCZ696雜質(zhì)，Lesinurad雜質(zhì)，瑞他帕林雜質(zhì)，酒石酸美托洛爾雜質(zhì)，法莫替丁雜質(zhì)，博舒替尼雜質(zhì)，環(huán)丙沙星雜質(zhì)，達(dá)托霉素雜質(zhì)，維格列汀雜質(zhì)，厄洛替尼雜質(zhì)，貝那普利雜質(zhì)，泰地唑胺雜質(zhì)，西米替丁雜質(zhì)，克霉唑雜質(zhì)，匹莫范色林雜質(zhì)，多索茶堿雜質(zhì)，喜樹(shù)堿雜質(zhì)，丁吡卡因雜質(zhì)，伏立康唑雜質(zhì)，吉非替尼雜質(zhì)，埃博霉素A雜質(zhì)，利伐沙班雜質(zhì)，氰美馬嗪雜質(zhì)